Cellectis S.A. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Cellectis S.A., a foreign private issuer headquartered in Paris, France, on May 12, 2026. The filing serves to distribute a press release dated May 12, 2026 (Exhibit 99.1) to U.S. investors. The registrant files annual reports under Form 20-F.
Financial Metrics
The provided filing text contains only the cover page and exhibit index. It does not include the content of the press release or any financial statements. Consequently, data regarding revenue, profit, cash flow, margins, debt, and liquidity is not present in this document.
Material Changes
No material changes versus prior periods can be identified as the source text lacks comparative financial data or operational updates.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, future guidance, risk factors, or details on contingencies. The specific content of the press release referenced in Exhibit 99.1 is not included in the input.
Key Facts for Investor Verification
- The filing is a procedural Form 6-K referencing an external press release (Exhibit 99.1) which is not included in the provided text.
- No financial figures or operational metrics are available in this specific document snippet.
- Investors must access the full press release dated May 12, 2026, to obtain the material information intended for disclosure.
- The report was signed by André Choulika, Chief Executive Officer.